ClinicalTrials.gov
ClinicalTrials.gov Menu

Progressive Muscle Relaxation and Cigarette Craving

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02153775
Recruitment Status : Completed
First Posted : June 3, 2014
Last Update Posted : June 3, 2014
Sponsor:
Information provided by (Responsible Party):
Rasmon Kalayasiri, Chulalongkorn University

Brief Summary:
Cigarette craving usually occurs with unpleasant feelings, including stress. Progressive Muscle Relaxation (PMR) may reduce level of cigarette craving and/or withdrawal symptoms.

Condition or disease Intervention/treatment Phase
Addiction Behavioral: Progressive Muscle Relaxation Not Applicable

Detailed Description:
The study reports on a study investigating the acute effects of a one-time application of progressive muscle relaxation on craving for cigarettes in smokers who were instructed to abstain from cigarettes for 3 hours.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Preliminary Study of Effects of Progressive Muscle Relaxation on Cigarette Craving and Withdrawal Symptoms of Experienced Smokers in Acute Cigarette Abstinence : A Randomised Control Trial
Study Start Date : August 2012
Actual Primary Completion Date : November 2012
Actual Study Completion Date : November 2012

Arm Intervention/treatment
Experimental: Progressive muscle relaxation
Progressive muscle relaxation: single 20-minutes session
Behavioral: Progressive Muscle Relaxation
Comparison of progressive muscle relaxation and no intervention (e.g., reading newspaper of the day) for the same amount of time.

No Intervention: Reading newspaper of the day
Reading newspaper of the day : single 20-minutes session



Primary Outcome Measures :
  1. Craving [ Time Frame: Immediately after a 20-minutes session of progressive muscle relaxation ]
    Craving, a strong desire for using a substance when abstaining from substance, was measured by the Penn Alcohol Rating Scale - adapted (PACS-adapted) and the Visual Analog Scale (VAS).


Secondary Outcome Measures :
  1. Cigarette withdrawal-related and non-withdrawal related feelings [ Time Frame: Immediately after a 20-minutes session of progressive muscle relaxation ]
    Cigarette withdrawal symptoms (i.e., anxious, hungry, feeling bad, restless) and non-withdrawal (i.e., high, stimulated, paranoid, tongue - tied) (59-61), as measured by using the Visual Analog Scale (VAS)


Other Outcome Measures:
  1. Blood pressure [ Time Frame: Immediately after a 20-minutes session of progressive muscle relaxation ]
    Systolic and diastolic blood pressure, measured by an automated machine

  2. Pulse rate [ Time Frame: Immediately after a 20-minutes session of progressive muscle relaxation ]
    Pulse rate, measured by an automated machine



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 years or more
  • Daily cigarette smokers

Exclusion Criteria:

  • Hospitalization
  • Participating in cigarette dependency treatment or trying to quit smoking with other methods
  • Uncontrolled blood pressure
  • Current other substance users (except alcohol)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02153775


Locations
Thailand
Department of Psychiatry, Faculty of Medicine, Chulalongkorn University
Bangkok, Thailand, 10330
Sponsors and Collaborators
Chulalongkorn University
Investigators
Principal Investigator: Thatsanee Limsanon, M.Sc. Chulalongkorn University

Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Rasmon Kalayasiri, Assistant Professor, Chulalongkorn University
ClinicalTrials.gov Identifier: NCT02153775     History of Changes
Other Study ID Numbers: IRB031/55
First Posted: June 3, 2014    Key Record Dates
Last Update Posted: June 3, 2014
Last Verified: May 2014

Keywords provided by Rasmon Kalayasiri, Chulalongkorn University:
Progressive muscle relaxation
Cigarette
Smoking
Craving